LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia
Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive...
Saved in:
Published in | Brain and behavior Vol. 12; no. 2; pp. e2466 - n/a |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.02.2022
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 2162-3279 2162-3279 |
DOI | 10.1002/brb3.2466 |
Cover
Abstract | Introduction
Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear.
Materials and methods
Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP‐response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting.
Results
In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model.
Conclusions
Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. |
---|---|
AbstractList | IntroductionSynaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear.Materials and methodsJuvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting.ResultsIn the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model.ConclusionsOur investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear. Materials and methods Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP‐response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting. Results In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model. Conclusions Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Synaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear.INTRODUCTIONSynaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear.Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting.MATERIALS AND METHODSJuvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting.In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model.RESULTSIn the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model.Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.CONCLUSIONSOur investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Synaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear. Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting. In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model. Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Abstract Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear. Materials and methods Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP‐response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting. Results In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model. Conclusions Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. |
Author | Li, Guo‐yan Lan, Yue Peng, Yuan An, Ying Li, Meng‐lin |
AuthorAffiliation | 1 Department of Rehabilitation Guangzhou First People's Hospital School of Medicine South China University of Technology Guangzhou China |
AuthorAffiliation_xml | – name: 1 Department of Rehabilitation Guangzhou First People's Hospital School of Medicine South China University of Technology Guangzhou China |
Author_xml | – sequence: 1 givenname: Meng‐lin surname: Li fullname: Li, Meng‐lin organization: South China University of Technology – sequence: 2 givenname: Yuan surname: Peng fullname: Peng, Yuan organization: South China University of Technology – sequence: 3 givenname: Ying surname: An fullname: An, Ying organization: South China University of Technology – sequence: 4 givenname: Guo‐yan surname: Li fullname: Li, Guo‐yan organization: South China University of Technology – sequence: 5 givenname: Yue surname: Lan fullname: Lan, Yue email: bluemooning@163.com organization: South China University of Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35025141$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks9uEzEQxleoiJbSAy-ALHGBQxr_390LUhMVqIhAisqBk-XdnU0cee1gb0LTB-C58SYtaivwxTOe7_tpbM_L7Mh5B1n2muBzgjEdV6Fi55RL-Sw7oUTSEaN5efQgPs7OYlzhtAThlOMX2TETmKaEnGS_Zz9YKXIh0Tr4zvcQ0dc5nSC4WQeI0XiHtkYjXfdmq_sh9S26-HI9ns4vJyiahdPWuAUyDvVLQKvNFpyxgDrolzurb_3Nbgi18xZ1pk4F34AdILFemlu_XoZk0K-y5622Ec7u9tPs-8fL6-nn0ezbp6vpxWxUC1zKUbpTzvIWC0Z4XpdSUMxrKTUVLZVStgRY03BaUl2ClEWFAUiKC8K4xLrR7DS7OnAbr1dqHUynw055bdT-wIeF0qE3tQWlaUNxU1R5wwTXgpdlVUEODZWF5FTTxPpwYK03VQdNDa4P2j6CPq44s1QLv1VFIQUROAHe3QGC_7mB2KvOxBqs1Q78JioqSSk4JyxP0rdPpCu_CentBxUjRVESyZLqzcOO_rZy_91JMD4I6uBjDNCq2vT7b00NGqsIVsNMqWGm1DBTyfH-ieMe-i_tHf1XmoDd_4VqMp-wveMPFJfZgg |
CitedBy_id | crossref_primary_10_1038_s41380_023_02065_4 crossref_primary_10_3389_fnins_2022_974940 crossref_primary_10_1016_j_expneurol_2022_114299 crossref_primary_10_2174_1570159X22666240206111838 crossref_primary_10_3390_biomedicines12051097 crossref_primary_10_1042_NS20210058 |
Cites_doi | 10.1093/schbul/sbp006 10.1038/sj.npp.1301604 10.1016/j.pnpbp.2015.02.012 10.1016/j.psychres.2019.112497 10.2174/1566523218666180302163029 10.1016/j.neuropharm.2007.05.018 10.1038/nrn3504 10.1016/j.nlm.2017.02.004 10.18632/oncotarget.7721 10.1371/journal.pone.0061787 10.1016/j.neuropharm.2011.06.007 10.1038/nature00928 10.2741/2190 10.1016/j.bbrc.2010.12.048 10.1016/j.tips.2008.10.006 10.1016/j.neuropharm.2018.05.019 10.1016/s0165‐0173(99)00044‐2 10.21037/apm-21-472 10.1017/s1461145713000928 10.1007/s00213‐016‐4230‐0 10.1016/j.mcn.2014.04.002 10.1016/s0140‐6736(09)60995‐8 10.1097/00001756‐200109170‐00043 10.1038/35085068 10.1016/j.bbr.2016.11.053 10.1016/j.pbb.2006.05.021 10.1111/j.1601‐183X.2009.00474.x 10.1038/npp.2012.180 10.1016/j.tins.2017.10.002 10.1038/nature09552 10.1126/stke.2001.94.pe1 10.1016/j.tins.2005.06.005 10.1186/s12888‐021‐03384‐y 10.1038/nm1632 10.1016/j.expneurol.2015.08.019 10.1074/jbc.273.49.32377 10.1126/science.281.5381.1349 10.1016/j.jad.2013.09.033 10.1007/s00403‐018‐1816‐x 10.1016/j.schres.2006.02.001 10.1007/s12011‐015‐0478‐1 10.1523/jneurosci.0792‐06.2006 10.1016/j.euroneuro.2017.03.005 10.1038/sj.mp.4001556 10.1016/j.neubiorev.2016.05.030 10.1111/jnc.14101 |
ContentType | Journal Article |
Copyright | 2022 The Authors. published by Wiley Periodicals LLC 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC. 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022 The Authors. published by Wiley Periodicals LLC – notice: 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC. – notice: 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88G 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M2M M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM DOA |
DOI | 10.1002/brb3.2466 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Psychology Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Open Access Journals url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | LI et al |
EISSN | 2162-3279 |
EndPage | n/a |
ExternalDocumentID | oai_doaj_org_article_a2d20d8b7d354a5499bbe7ed268642a2 PMC8865150 35025141 10_1002_brb3_2466 BRB32466 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Beijing China United States--US China |
GeographicLocations_xml | – name: China – name: Beijing China – name: United States--US |
GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 81701318 – fundername: ; grantid: 81701318 |
GroupedDBID | 0R~ 1OC 24P 53G 5VS 7X7 8-0 8-1 8FI 8FJ 8G5 AAHHS AAZKR ABDBF ABUWG ACCFJ ACCMX ACGFO ACUHS ACXQS ADBBV ADKYN ADRAZ ADZMN ADZOD AEEZP AENEX AEQDE AFKRA AHMBA AIAGR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU D-8 D-9 DIK DWQXO EBS EJD ESX FYUFA GNUQQ GODZA GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR ITC KQ8 M2M M2O M48 M~E OK1 PIMPY PQQKQ PROAC PSYQQ RNS RPM SUPJJ TUS UKHRP WIN AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c5096-216737f053147c965204c66a25f2666f1e3dd4292a9e668b0ee12a9813460ada3 |
IEDL.DBID | 7X7 |
ISSN | 2162-3279 |
IngestDate | Wed Aug 27 01:25:07 EDT 2025 Thu Aug 21 18:34:14 EDT 2025 Fri Sep 05 11:45:52 EDT 2025 Sun Jul 13 04:52:19 EDT 2025 Wed Feb 19 02:26:24 EST 2025 Tue Jul 01 02:08:42 EDT 2025 Thu Apr 24 23:09:44 EDT 2025 Wed Jan 22 16:27:05 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | NR2B LY395756 CREB schizophrenia |
Language | English |
License | Attribution 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5096-216737f053147c965204c66a25f2666f1e3dd4292a9e668b0ee12a9813460ada3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2631889163?pq-origsite=%requestingapplication% |
PMID | 35025141 |
PQID | 2631889163 |
PQPubID | 976341 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a2d20d8b7d354a5499bbe7ed268642a2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8865150 proquest_miscellaneous_2619544137 proquest_journals_2631889163 pubmed_primary_35025141 crossref_citationtrail_10_1002_brb3_2466 crossref_primary_10_1002_brb3_2466 wiley_primary_10_1002_brb3_2466_BRB32466 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2022 |
PublicationDateYYYYMMDD | 2022-02-01 |
PublicationDate_xml | – month: 02 year: 2022 text: February 2022 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Los Angeles – name: Hoboken |
PublicationTitle | Brain and behavior |
PublicationTitleAlternate | Brain Behav |
PublicationYear | 2022 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
References | 2017; 40 2010; 11 1998; 281 2021; 21 2010; 468 2017; 27 2009 2009; 374 2002; 418 2008; 33 2016; 70 2007; 53 2013; 8 2005; 28 2007; 12 2014; 60 2007; 13 1998; 273 2015; 273 2018; 18 2009; 35 2016; 7 2009; 30 2021; 10 2019; 280 2013; 14 2011; 404 2006; 84 2013; 16 2013; 38 2015; 60 2018; 310 2018; 137 2006; 26 2000; 31 2016; 233 2014; 152‐154 2005; 10 2009; 8 2017; 140 2001; 2 2017; 143 2001; 12 2016; 170 2001; 2001 2017; 325 2012; 62 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_49_1 e_1_2_7_28_1 e_1_2_7_29_1 Petralia R. S. (e_1_2_7_40_1) 2009 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 Mezler M. (e_1_2_7_32_1) 2010; 11 |
References_xml | – volume: 280 year: 2019 article-title: PKA‐mediated phosphorylation of CREB and NMDA receptor 2B in the hippocampus of offspring rats is involved in transmission of mental disorders across a generation publication-title: Psychiatry Research – volume: 18 start-page: 45 issue: 1 year: 2018 end-page: 63 article-title: Dysfunction in brain‐derived neurotrophic factor signaling pathway and susceptibility to schizophrenia, Parkinson's and Alzheimer's diseases publication-title: Current Gene Therapy – year: 2009 – volume: 84 start-page: 392 issue: 3 year: 2006 end-page: 399 article-title: Effects of the mGluR2/3 agonist LY379268 on ketamine‐evoked behaviours and neurochemical changes in the dentate gyrus of the rat publication-title: Pharmacology, Biochemistry and Behavior – volume: 60 start-page: 66 year: 2015 end-page: 76 article-title: Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end? publication-title: Progress in Neuro‐Psychopharmacology & Biological Psychiatry – volume: 33 start-page: 2175 issue: 9 year: 2008 end-page: 2186 article-title: Lamina‐specific abnormalities of NMDA receptor‐associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder publication-title: Neuropsychopharmacology – volume: 404 start-page: 711 issue: 2 year: 2011 end-page: 716 article-title: CREB is a regulatory target for the protein kinase Akt/PKB in the differentiation of pancreatic ductal cells into islet β‐cells mediated by hepatocyte growth factor publication-title: Biochemical and Biophysical Research Communications – volume: 152‐154 start-page: 326 year: 2014 end-page: 333 article-title: Alteration of cyclic‐AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia publication-title: Journal of Affective Disorders – volume: 16 start-page: 2181 issue: 10 year: 2013 end-page: 2194 article-title: Translating the N‐methyl‐D‐aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia publication-title: The International Journal of Neuropsychopharmacology – volume: 21 start-page: 373 issue: 1 year: 2021 article-title: Understanding factors relevant to poor sleep and coping methods in people with schizophrenia publication-title: BMC Psychiatry – volume: 27 start-page: 470 issue: 5 year: 2017 end-page: 483 article-title: The involvement of BDNF‐CREB signaling pathways in the pharmacological mechanism of combined SSRI‐ antipsychotic treatment in schizophrenia publication-title: European Neuropsychopharmacology – volume: 35 start-page: 549 issue: 3 year: 2009 end-page: 562 article-title: The dopamine hypothesis of schizophrenia: Version III—the final common pathway publication-title: Schizophrenia Bulletin – volume: 40 start-page: 720 issue: 12 year: 2017 end-page: 733 article-title: Emerging roles of CREB‐regulated transcription coactivators in brain physiology and pathology publication-title: Trends in Neuroscience – volume: 374 start-page: 635 issue: 9690 year: 2009 end-page: 645 article-title: Schizophrenia publication-title: Lancet – volume: 8 issue: 4 year: 2013 article-title: Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons publication-title: PLoS One – volume: 2 start-page: 599 issue: 8 year: 2001 end-page: 609 article-title: Transcriptional regulation by the phosphorylation‐dependent factor CREB publication-title: Nature Reviews Molecular Cell Biology – volume: 26 start-page: 4690 issue: 17 year: 2006 end-page: 4700 article-title: Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation‐dependent subunit trafficking publication-title: Journal of Neuroscience – volume: 12 start-page: 1814 year: 2007 end-page: 1832 article-title: Multisite phosphorylation of the cAMP response element‐binding protein (CREB) by a diversity of protein kinases publication-title: Frontiers in Bioscience – volume: 60 start-page: 63 year: 2014 end-page: 71 article-title: Dynorphin up‐regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B‐containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways publication-title: Molecular and Cellular Neuroscience – volume: 137 start-page: 359 year: 2018 end-page: 371 article-title: Juvenile treatment with mGluR2/3 agonist prevents schizophrenia‐like phenotypes in adult by acting through GSK3β publication-title: Neuropharmacology – volume: 70 start-page: 260 year: 2016 end-page: 270 article-title: Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model publication-title: Neuroscience and Biobehavioral Reviews – volume: 281 start-page: 1349 issue: 5381 year: 1998 end-page: 1352 article-title: Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats publication-title: Science – volume: 14 start-page: 383 issue: 6 year: 2013 end-page: 400 article-title: NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease publication-title: Nature Reviews Neuroscience – volume: 233 start-page: 1349 issue: 8 year: 2016 end-page: 1359 article-title: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two‐hit mouse model of schizophrenia publication-title: Psychopharmacology – volume: 143 start-page: 320 issue: 3 year: 2017 end-page: 333 article-title: Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia publication-title: Journal of Neurochemistry – volume: 325 start-page: 79 issue: Pt A year: 2017 end-page: 86 article-title: Autophagy and Akt/CREB signalling play an important role in the neuroprotective effect of nimodipine in a rat model of vascular dementia publication-title: Behavioural Brain Research – volume: 13 start-page: 1102 issue: 9 year: 2007 end-page: 1107 article-title: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial publication-title: Nature Medicine – volume: 30 start-page: 25 issue: 1 year: 2009 end-page: 31 article-title: Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia publication-title: Trends in Pharmacological Sciences – volume: 8 start-page: 320 issue: 3 year: 2009 end-page: 329 article-title: RNA interference in hippocampus demonstrates opposing roles for CREB and PP1alpha in contextual and temporal long‐term memory publication-title: Genes, Brain, and Behavior – volume: 140 start-page: 52 year: 2017 end-page: 61 article-title: Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia publication-title: Neurobiology of Learning and Memory – volume: 11 start-page: 833 issue: 7 year: 2010 end-page: 845 article-title: LY‐2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY‐404039 for the potential treatment of schizophrenia publication-title: Current Opinion in Investigational Drugs – volume: 273 start-page: 190 year: 2015 end-page: 201 article-title: LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801‐induced working memory impairment publication-title: Experimental Neurology – volume: 10 start-page: 4479 issue: 4 year: 2021 end-page: 4485 article-title: Poor sleep quality and its related risk factors among university students publication-title: Annals of Palliative Medicine – volume: 170 start-page: 366 issue: 2 year: 2016 end-page: 372 article-title: Role of PTEN‐Akt‐CREB signaling pathway in nervous system impairment of rats with chronic arsenite exposure publication-title: Biological Trace Element Research – volume: 62 start-page: 1473 issue: 3 year: 2012 end-page: 1483 article-title: Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia publication-title: Neuropharmacology – volume: 10 start-page: 79 issue: 1 year: 2005 end-page: 104 article-title: Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs publication-title: Molecular Psychiatry – volume: 273 start-page: 32377 issue: 49 year: 1998 end-page: 32379 article-title: CREB is a regulatory target for the protein kinase Akt/PKB publication-title: Journal of Biological Chemistry – volume: 418 start-page: 970 issue: 6901 year: 2002 end-page: 975 article-title: Protein phosphatase 1 is a molecular constraint on learning and memory publication-title: Nature – volume: 310 start-page: 187 issue: 3 year: 2018 end-page: 196 article-title: The stem cell factor‐stimulated melanogenesis in human melanocytes can be abrogated by interrupting the phosphorylation of MSK1: Evidence for involvement of the p38/MSK1/CREB/MITF axis publication-title: Archives of Dermatological Research – volume: 468 start-page: 187 issue: 7321 year: 2010 end-page: 693 article-title: Rethinking schizophrenia publication-title: Nature – volume: 7 start-page: 35454 issue: 23 year: 2016 end-page: 35465 article-title: Control of CREB expression in tumors: From molecular mechanisms and signal transduction pathways to therapeutic target publication-title: Oncotarget – volume: 31 start-page: 288 issue: 2‐3 year: 2000 end-page: 294 article-title: Glutamate receptor expression in schizophrenic brain publication-title: Brain Research Brain Research Reviews – volume: 38 start-page: 328 issue: 2 year: 2013 end-page: 340 article-title: Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning publication-title: Neuropsychopharmacology – volume: 12 start-page: 2971 issue: 13 year: 2001 end-page: 2974 article-title: Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses publication-title: NeuroReport – volume: 28 start-page: 436 issue: 8 year: 2005 end-page: 445 article-title: The many faces of CREB publication-title: Trends in Neuroscience – volume: 2001 issue: 94 year: 2001 article-title: New roles for introns: Sites of combinatorial regulation of Ca2+‐ and cyclic AMP‐dependent gene transcription publication-title: Science Signaling – volume: 53 start-page: 362 issue: 3 year: 2007 end-page: 368 article-title: Regulation of NMDA receptors by phosphorylation publication-title: Neuropharmacology – volume: 84 start-page: 214 issue: 2–3 year: 2006 end-page: 221 article-title: N‐methyl‐D‐aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels publication-title: Schizophrenia Research – ident: e_1_2_7_16_1 doi: 10.1093/schbul/sbp006 – ident: e_1_2_7_2_1 doi: 10.1038/sj.npp.1301604 – volume: 11 start-page: 833 issue: 7 year: 2010 ident: e_1_2_7_32_1 article-title: LY‐2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY‐404039 for the potential treatment of schizophrenia publication-title: Current Opinion in Investigational Drugs – ident: e_1_2_7_24_1 doi: 10.1016/j.pnpbp.2015.02.012 – ident: e_1_2_7_18_1 doi: 10.1016/j.psychres.2019.112497 – ident: e_1_2_7_35_1 doi: 10.2174/1566523218666180302163029 – ident: e_1_2_7_5_1 doi: 10.1016/j.neuropharm.2007.05.018 – ident: e_1_2_7_37_1 doi: 10.1038/nrn3504 – ident: e_1_2_7_23_1 doi: 10.1016/j.nlm.2017.02.004 – ident: e_1_2_7_46_1 doi: 10.18632/oncotarget.7721 – ident: e_1_2_7_48_1 doi: 10.1371/journal.pone.0061787 – ident: e_1_2_7_10_1 doi: 10.1016/j.neuropharm.2011.06.007 – ident: e_1_2_7_12_1 doi: 10.1038/nature00928 – ident: e_1_2_7_21_1 doi: 10.2741/2190 – ident: e_1_2_7_26_1 doi: 10.1016/j.bbrc.2010.12.048 – ident: e_1_2_7_6_1 doi: 10.1016/j.tips.2008.10.006 – ident: e_1_2_7_49_1 doi: 10.1016/j.neuropharm.2018.05.019 – ident: e_1_2_7_30_1 doi: 10.1016/s0165‐0173(99)00044‐2 – ident: e_1_2_7_27_1 doi: 10.21037/apm-21-472 – ident: e_1_2_7_31_1 doi: 10.1017/s1461145713000928 – ident: e_1_2_7_9_1 doi: 10.1007/s00213‐016‐4230‐0 – ident: e_1_2_7_43_1 doi: 10.1016/j.mcn.2014.04.002 – ident: e_1_2_7_47_1 doi: 10.1016/s0140‐6736(09)60995‐8 – ident: e_1_2_7_22_1 doi: 10.1097/00001756‐200109170‐00043 – ident: e_1_2_7_29_1 doi: 10.1038/35085068 – ident: e_1_2_7_17_1 doi: 10.1016/j.bbr.2016.11.053 – ident: e_1_2_7_19_1 doi: 10.1016/j.pbb.2006.05.021 – ident: e_1_2_7_39_1 doi: 10.1111/j.1601‐183X.2009.00474.x – ident: e_1_2_7_45_1 doi: 10.1038/npp.2012.180 – ident: e_1_2_7_44_1 doi: 10.1016/j.tins.2017.10.002 – ident: e_1_2_7_20_1 doi: 10.1038/nature09552 – ident: e_1_2_7_11_1 doi: 10.1126/stke.2001.94.pe1 – volume-title: Biology of the NMDA receptor year: 2009 ident: e_1_2_7_40_1 – ident: e_1_2_7_3_1 doi: 10.1016/j.tins.2005.06.005 – ident: e_1_2_7_4_1 doi: 10.1186/s12888‐021‐03384‐y – ident: e_1_2_7_38_1 doi: 10.1038/nm1632 – ident: e_1_2_7_25_1 doi: 10.1016/j.expneurol.2015.08.019 – ident: e_1_2_7_7_1 doi: 10.1074/jbc.273.49.32377 – ident: e_1_2_7_34_1 doi: 10.1126/science.281.5381.1349 – ident: e_1_2_7_42_1 doi: 10.1016/j.jad.2013.09.033 – ident: e_1_2_7_36_1 doi: 10.1007/s00403‐018‐1816‐x – ident: e_1_2_7_28_1 doi: 10.1016/j.schres.2006.02.001 – ident: e_1_2_7_41_1 doi: 10.1007/s12011‐015‐0478‐1 – ident: e_1_2_7_15_1 doi: 10.1523/jneurosci.0792‐06.2006 – ident: e_1_2_7_8_1 doi: 10.1016/j.euroneuro.2017.03.005 – ident: e_1_2_7_33_1 doi: 10.1038/sj.mp.4001556 – ident: e_1_2_7_13_1 doi: 10.1016/j.neubiorev.2016.05.030 – ident: e_1_2_7_14_1 doi: 10.1111/jnc.14101 |
SSID | ssj0000514240 |
Score | 2.2693713 |
Snippet | Introduction
Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental... Synaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM)... IntroductionSynaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental... Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway... Abstract Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental... |
SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e2466 |
SubjectTerms | Amino Acids, Dicarboxylic Animal cognition Animals Bridged Bicyclo Compounds Cognitive ability CREB Cyclic AMP Response Element-Binding Protein - metabolism Disease Models, Animal Drug dosages Fluorides Laboratory animals LY395756 Methylazoxymethanol Acetate - analogs & derivatives Mice NR2B Original Phosphorylation Proteins Proto-Oncogene Proteins c-akt - metabolism Receptors, N-Methyl-D-Aspartate - metabolism Schizophrenia Schizophrenia - chemically induced Signal Transduction |
SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB0hDohL1Q9K01LkIg69RJs4juMcGwRCVeGwAglOlh076larBLFsBf0B_d2dcbLLrqDqpTcrdizHHnue4_F7AIe1wHUx9T5unHGx4LyOy7JOYuI-z4SyvpdOODuXp5fi61V-tSL1RTFhPT1w33Ejwx1PnLKFy3JhaDdjrS-841IhdDZh9UU3trKZWrB6o69aUAklfGRvcdfIRWBDfHRAgaf_OXD5NEZyFbsG53PyEl4MqJF96Vv7CjZ8-xq2zoZz8Tfw-9s1nYTlkt2E8Do_Y-djXjF_P8S5tuznxDC6xND_gmVdwxDejY7GxxWjGA5D19LZpGUICNmPOS6B2A5G-tIPU_Oru3-gpGm7KSP9ehYEdKiS2WrQ3g5cnhxfHJ3Gg8JCXBPtS8xTkqlpaCKKoi5lzhNRS2l43qDjlk3qM-dI0MqUXkplE-9TTKs0EzIxzmRvYbPtWv8OmBJlrbAOyz2J_xZl0lhhZNrgq40seQSfF92u64F-nFQwpronTuaaRkjTCEVwsCx603NuPFeoorFbFiCa7PAAjUcPxqP_ZTwR7C1GXg9zd6a5xHVOIWzOIvi0zMZZR0cppvXdnMoQUx4CgCKC3d5Qli3Jctq3iTSCYs2E1pq6ntNOvgdmb6VImT7BvgrG9vev19W4yijx_n90wwfY5nSrIwSj78Hm3e3cf0SsdWf3w7T6A1LJJg8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGkBAviPG1wIYMQoiXsMRxHOcBITJtmhDdQ0Wl8WQ5sQOdqqRrV9TyB_B3c-c4VSsKb1biWP64893F59-PkDcVh30xtjasjTYhZ6wK87yKQsQ-T7gsbUedMLgUFyP--Sq92iN9WrOfwPnO0A75pEazyfvlzeojKPwHDyB6Us4gIGRciLfTmxD5pPDc1ZNr3CF3wUYxlPeBd_x71G-wZT3U0GYjWwbK4fjvcj7_zqHc9G2dcTp_SB54r5J-6sTggOzZ5hG5N_Dn5o_J7y_f8KQsFXTq0u_snF4OWUHt0ufBNvTnWFO85ND9oqVtTcH9OzkdnhUUczw0Xlun44aCw0ivF7BFQj8o8k-vJvpXu1xhUTfthCK_PXUEO9jIfDOp7wkZnZ99Pb0IPQNDWCEsTMhipLGpUVF5VuUiZRGvhNAsrcGwizq2iTFIeKVzK4QsI2tjKMs44SLSRidPyX7TNvaQUMnzSkIbJbNIDpzlUV1yLeIaPq1FzgLyrp92VXl4cmTJmKgOWJkpXCGFKxSQ1-uq0w6TY1elAtduXQFhtN2DdvZdea1UmhkWGVlmJkm5xlC5LG1mDRMS4jINnTrqV171oqmYgH1QgludBOTV-jVoJR616Ma2C6yDSHrgIGQBedYJyronSYpxHY8Dkm2J0FZXt9804x8O-VtKZK6PYK6csP179KoYFgkWnv9_BC_IfYb3OVwa-hHZv50t7DF4WbflS6cwfwCtgia- priority: 102 providerName: Scholars Portal – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVKkRAXxDcpBRnEgUu0ydhxHHEiVasK0QqtqFROkR07ZdEqqXa7VcsP4Hcz42RDVxSJm5WMI8fjscf2zHuMvaslzoup93HjjIslQB0XRZ3EhH0upLa-p044OlaHJ_LTaXa6xT6sc2F6fIjxwI0sI8zXZODGLid_QEPtAreBIJW6w-6mtOoTrLP8Mh6wELA3hIRISBXEAvJijSyUwGSsvbEeBdj-23zNv0Mmb7qyYS06eMgeDE4k_9hr_RHb8u1jdu9ouCZ_wn59_kYXY5ni5yHazi_58RRK7q-GsNeWX84Mp5yG_kSWdw1Hb2-yN90vOYV0GMpS57OWo3_If6xwRsR2cKKbvp6bn93VNRVN28050dnzwKdDH1nejOF7yk4O9r_uHcYD4UJcEwpMjB2Vi7whu5R5XagMElkrZSBrcB1XTeqFc8RvZQqvlLaJ9ymWdSqkSowz4hnbbrvWv2Bcy6LW-A0LnriA8yJprDQqbbBqowqI2Pt1t1f1gEZOpBjzqsdRhoo0VJGGIvZ2FD3vIThuEypJd6MAoWaHB93irBqMsDLgIHHa5k5k0tDO2FqfewdK4zbMYKN215qvBlNeVqBw2tPoRYuIvRlfoxHSzYppfbciGQLOQ38gj9jzfqCMLREZbeNkGrF8YwhtNHXzTTv7HoC-tSai-gT7Kgy2f_99VU5LQYWd_xd9ye4DpXKECPRdtn2xWPlX6GBd2NfBkH4DaxsfSQ priority: 102 providerName: Wiley-Blackwell |
Title | LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbrb3.2466 https://www.ncbi.nlm.nih.gov/pubmed/35025141 https://www.proquest.com/docview/2631889163 https://www.proquest.com/docview/2619544137 https://pubmed.ncbi.nlm.nih.gov/PMC8865150 https://doaj.org/article/a2d20d8b7d354a5499bbe7ed268642a2 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: KQ8 dateStart: 20110101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate - eBooks customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: ABDBF dateStart: 20140501 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: DIK dateStart: 20110101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: RPM dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: 7X7 dateStart: 20110901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: BENPR dateStart: 20110901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2162-3279 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: M48 dateStart: 20110901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVWIB databaseName: KBPluse Wiley Online Library: Open Access customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: AVUZU dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Open Access Journals customDbUrl: eissn: 2162-3279 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000514240 issn: 2162-3279 databaseCode: 24P dateStart: 20110101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELbYJiFeEL_JGJVBPPASNXEcx3lCZOo0IVpNFZPKU-TYDhRVSWnXaeMP4O_mznGzVQxeIitxIjt3Z5_P5-8j5J3mMC7G1oa1USbkjOkwz3UUIvZ5wmVlO-qE8UScnvNPs3TmA25rn1a5HRPdQG1ajTHyIROgfRKcmeTD8meIrFG4u-opNPbIQQyuCmp1Nsv6GAtie8OMtQUUitiwWsHakXGHiXgzDTm0_rtczL8zJW97sG4KOnlEHnrfkX7shP2Y3LPNE3J_7HfHn5Lfn7_iflgq6NIl2dk1nUxZQe2Vz3Zt6OVcUTzK0AViaVtTcPKGx9NRQTGTQ-HhdDpvKLiF9McGBkJoB0WW6euF-tVeXWNRNe2CIos9dTQ6-JH17dS9Z-T8ZPTl-DT0PAuhRvCXkMVIVlOjOfJM5yJlEddCKJbWMH2LOraJMUhrpXIrhKwia2MoyzjhIlJGJc_JftM29iWhkudawjcqZpECOMujuuJKxDW8WoucBeT99reX2oOQIxfGouzgk1mJEipRQgF521dddsgbd1UqUHZ9BQTLdjfa1bfS216pmGGRkVVmkpQrXBBXlc2sYULC6ktBo462ki-9Ba_LG30LyJv-MdgebqioxrYbrIN4eeAGZAF50SlK35IkxdUbjwOS7ajQTlN3nzTz7w7fW0rkp4_gXzll-3fvy2JaJFg4_H8PXpEHDE9tuGTzI7J_sdrY1-BLXVQDssf42cCZzYAcFKPJ2XTg4hJwHXP5B5EBIcI |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH8CAwwCiZeoieM4zgNCZGzqWNuHapPKU-bEDutUktKusPIB-Dh8Ru6cpFvF4G1vVuJYdu58vrPPvx8hr3MOdtE3xi200i5nLHfjOPdcxD4PuMxMTZ3QH4juIf80Ckcb5Hd7FwbTKlubaA21rnLcI-8wAdonwZkJ3k-_ucgahaerLYVGrRb7ZvkDQrb5u72PIN83jO3uHGx33YZVwM0R6sRlPlKzFKh8PMpjETKP50IoFhawWInCN4HWSOKkYiOEzDxjfChLP-DCU1oF0O41ch3GyBGrPxpFqz0dxBKHFbIFMPJYJ5tBrMq4xWA8X_YsO8BlLu3fmZkXPWa75O3eIbcbX5V-qJXrLtkw5T1yo9-cxt8nv3qf8fwtFHRqk_rMnA6GLKHmrMmuLen3saJ4daLe-KVVQcGp7GwPdxKKmSMKL8PTcUnBDaUnCzC80A-KrNbLifpZnS2xqMpqQr-CQaOWtgcbmV9MFXxADq9EAg_JZlmV5jGhkse5hDYyZpByOIq9IuNK-AV8WoiYOeRt-9vTvAE9R-6NSVrDNbMUJZSihBzyalV1WiN9XFYpQdmtKiA4t31Qzb6kzVxPFdPM0zKLdBByhQF4lpnIaCYkRHsKOrXVSj5tLMY8Pddvh7xcvYa5jgc4qjTVAusgPh-4HZFDHtWKsupJEGK0yH2HRGsqtNbV9Tfl-NjiiUspwKv14F9ZZfv36NNkmARYePL_EbwgN7sH_V7a2xvsPyW3GN4YsYnuW2TzdLYwz8CPO82e28lDydFVz9Y_7LFXZg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGkCZeEHcCAwwCiZeoie04yQNCZFu1sa1CFZPKk3ESh3UqSWlXWPkB_Ch-Hec4l61i8LY3q3EtJ-fic-zj7yPkZSbAL_rGuEWuc1cwlrlxnHkuYp9zEaWmpk44HMjdI_F-FIzWyO_2LgyWVbY-0TrqvMpwj7zHJGhfBMEM7xVNWcSH7f7b6TcXGaTwpLWl06hVZN8sf0D6Nn-ztw2yfsVYf-fj1q7bMAy4GcKeuMxHmpYCFVGEWSwD5olMSs2CAhYuWfiG5zkSOunYSBmlnjE-tCOfC-npXHMY9xq5HnLBsZwsHIXd_g7iisNq2YIZeayXziBvZcLiMZ4vgZYp4LLw9u8qzYvRs13--rfIzSZupe9qRbtN1kx5h2wcNifzd8mvg094FhdIOrUFfmZOB0OWUHPWVNqW9PtYU7xGUW8C06qgEGD2toY7CcUqEo0X4-m4pBCS0pMFOGGYB0WG6-VE_6zOltjUZTWhX8G5UUvhg4PML5YN3iNHVyKB-2S9rErzkNBIxFkEY6TMIP1wGHtFKrT0C_hrIWPmkNftZ1dZA4COPBwTVUM3M4USUighh7zouk5r1I_LOiUou64DAnXbH6rZF9XYvdIsZ14epWHOA6ExGU9TE5qcyQgyPw2T2mwlrxrvMVfnuu6Q591jsHs8zNGlqRbYB7H6IAQJHfKgVpRuJjzAzFH4DglXVGhlqqtPyvGxxRaPIgkRrgffyirbv99eJcOEY-PR_9_gGdkAO1UHe4P9x-QGw8sjtuZ9k6yfzhbmCYR0p-lTazuUfL5qY_0DJEFboQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LY395756+promotes+NR2B+expression+via+activation+of+AKT%2FCREB+signaling+in+the+juvenile+methylazoxymethanol+mice+model+of+schizophrenia&rft.jtitle=Brain+and+behavior&rft.au=Meng-lin%2C+Li&rft.au=Yuan%2C+Peng&rft.au=An%2C+Ying&rft.au=Guo-yan%2C+Li&rft.date=2022-02-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=2162-3279&rft.volume=12&rft.issue=2&rft_id=info:doi/10.1002%2Fbrb3.2466&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-3279&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-3279&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-3279&client=summon |